Head-to-head
Retatrutide vs Tirzepatide
Both are next-generation GLP-1-based weight loss agents. Retatrutide is the triple agonist (adds glucagon receptor); Tirzepatide is the dual GLP-1/GIP agonist already on market. Choosing between them depends on whether visceral fat or broader GLP-1 receptor benefits matter more.
Side by side
| Feature | Retatrutide | Tirzepatide |
|---|---|---|
| Receptor targets | GLP-1 + GIP + Glucagon (triple) | GLP-1 + GIP (dual) |
| FDA status | Phase 3 (investigational) | FDA-approved (Mounjaro, Zepbound) |
| Trial weight loss (24 weeks) | ~24% mean reduction | ~21% mean reduction |
| Visceral fat reduction | Strong (glucagon-driven) | Moderate |
| Lean mass preservation | Best in class for lifters (Bachmeyer) | Strong but second |
| Carb requirement | 40–55% carbs needed (glucagon receptor) | Flexible — keto-compatible |
| Half-life | ~6 days | ~5 days |
| Starting dose | 0.25–0.5 mg/week | 0.5–2.5 mg/week |
| Therapeutic dose | 4–8 mg/week | 5–15 mg/week |
| Approximate cost | $400–600/mo (compounded) | $300–500/mo (compounded); $1,000+ brand |
Who wins, by goal
Visceral fat reduction
Glucagon receptor activation drives hepatic fat oxidation specifically.
Brain / immune / joint benefits
Dr. Tyna Moore: Reta has 'very little actual GLP-1 component' for those targets. Tirzepatide hits the GLP-1 receptor more cleanly.
Lifters / lean mass preservation
Bachmeyer, Jones DC, and Jay Campbell all rate Reta superior for lifters — 40% new mitochondria, glucagon-driven fat loss preserves muscle.
Predictable side effects / proven safety
Tirzepatide has multi-year FDA Phase 4 data. Retatrutide is still investigational.
Keto / low-carb dieters
Reta's glucagon receptor effectiveness drops ~40% on low-carb. Tirz is dose-flexible across diets.
Where the experts land
Dr. Bachmeyer, Dr. Jones DC, Jay Campbell endorse Retatrutide as superior for lifters. Dr. Tyna Moore prefers Tirzepatide for non-lifters wanting GLP-1 receptor benefits. Hunter Williams calls Reta + Tirz 'dangerous combo' warnings clickbait — disagreement exists.
Bottom line
If you lift and want to preserve muscle while cutting visceral fat: Retatrutide. If you want the more proven, more flexible compound and don't care about the glucagon edge: Tirzepatide. Never stack them — Bachmeyer warns of 'metabolic whiplash' and 60% regain in 6 months.